Literature DB >> 15939

The differential diagnosis of crescentic glomerulonephritis. The pathology of specific lesions with prognostic implications.

B H Spargo, N G Ordóñez, J C Ringus.   

Abstract

Combined findings from light and electron microscopy with immunofluorescence studies make a definitive diagnosis possible in most cases of crescentic glomerulonephritis. The patient's prognosis and pattern of response to therapy are matters of immediate concern in the light of recent developments in nephrology. The frequency of crescentic lesions varies depending on the specific types of disease, but the idiopathic lesion is seldom seen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 15939     DOI: 10.1016/s0046-8177(77)80080-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Immunoperoxidase autopsy study of crescentic glomerulonephritis with extracapillary proliferation.

Authors:  T Tóth
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

2.  Demonstration of immune complex deposits by electron microscopy and immunofluorescence in a fatal case of hypersensitivity angiitis.

Authors:  A Magil; L Calderon; S Gershon
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

3.  Plasmapheresis and severe glomerulonephritis.

Authors: 
Journal:  Br Med J       Date:  1979-02-17

4.  'Pulse' methylprednisolone and cyclophosphamide therapy in idiopathic rapidly progressive glomerulonephritis.

Authors:  G Friedman; H Granot; Y Koplovic; M Friedlander
Journal:  Postgrad Med J       Date:  1981-01       Impact factor: 2.401

Review 5.  Malignant or accelerated hypertension.

Authors:  N D Vaziri
Journal:  West J Med       Date:  1984-04

6.  Rapidly progressive glomerulonephritis with glomerular crescent formation in rheumatoid arthritis.

Authors:  F C Breedveld; R M Valentijn; M L Westedt; J J Weening
Journal:  Clin Rheumatol       Date:  1985-09       Impact factor: 2.980

7.  Treatment of non anti-GBM-antibody mediated, rapidly progressive glomerulonephritis by plasmapheresis and immunosuppression.

Authors:  G A Müller; L Seipel; T Risler
Journal:  Klin Wochenschr       Date:  1986-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.